Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Real-World Use of Bone-Modifying Agents in Metastatic Castration-Sensitive Prostate CancerJ. Natl. Cancer Inst 2021 Oct 01;[EPub Ahead of Print], AP Mitchell, A Mishra, KS Panageas, A Lipitz-Snyderman, PB Bach, MJ Morris
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.